An algorithm based on serum BMP2 levels and clinically relevant variables to NAFLD showed an AUROC of 0.886 (95%CI, 0.83–0.94) to discriminate NASH. The gene discussed is BMP2; the disease is metabolic dysfunction-associated steatohepatitis.